Le Lézard
Classified in: Health
Subjects: NPT, WOM, FEA

One-of-a-Kind Transplant Pregnancy Registry International Celebrates 30 Year Anniversary


PHILADELPHIA, May 4, 2021 /PRNewswire/ -- The Transplant Pregnancy Registry International (TPRI), a one-of-a-kind institution in the world, is celebrating a major milestone: 30 years of work to support thousands of pregnancies among people who have received organ transplants.

"We now know it is possible to have a safe pregnancy after receiving an organ transplant," said Lisa Coscia, TPRI.

TPRI is an ongoing research study focused on the effects of pregnancy on transplant recipients and the effects of immunosuppressive medications on fertility and pregnancy outcomes. At one time, many transplant recipients were warned not to attempt pregnancy. TPRI's work helped change the conversation. 

"Thanks to visionary researchers and thousands of women and men around the world who have contributed to our study, we now know that it is possible to have a safe pregnancy after receiving an organ transplant. There is nothing more gratifying than letting someone know that parenthood is within their reach," said Lisa Coscia, RN, BSN, CCTC, Research Coordinator at TPRI.

For decades, the medical community had a big problem when it came to transplants and pregnancy: extremely limited data. Researchers need large population groups to study treatments and risks, but the number of transplant recipients who have children is relatively small. TPRI fills that gap by collecting data from transplant recipients around the world.

Since its founding 30 years ago, the Transplant Pregnancy Registry International team and its collaborators have:

Despite the progress, there is more to learn. At this time, it is not advisable for every transplant recipient who wants to have children to do so. Certain risks may be too great for some individuals. TPRI's research will continue.

"When an organ transplant recipient welcomes a child into the world, it is a miracle on top of a miracle. TPRI offers transplant recipients and their healthcare teams a tremendous family planning resource, providing important information that has enabled new generations," said Howard M. Nathan, President and CEO of the Gift of Life Donor Program.

For information about Transplant Pregnancy Registry International, visit transplantpregnancyregistry.org.

For information about Gift of Life Donor Program, visit donors1.org.

For information about Gift of Life Institute, visit giftoflifeinstitute.org.

SOURCE Transplant Pregnancy Registry International


These press releases may also interest you

at 06:59
-- Completed enrollment in bempikibart alopecia areata (AA) Phase 2 clinical trial, with topline results expected in Q4'24; enrollment in bempikibart atopic dermatitis (AD) Phase 2 clinical trial remains on-track, with topline results expected in...

at 06:59
Reports Total Revenues of $3.66 Billion; U.S. GAAP Net Earnings of $113.9 Million; Adjusted EBITDA of $1.19 Billion; U.S. GAAP EPS of $0.09; Adjusted EPS of $0.67; U.S. GAAP Net Cash Provided by Operating Activities of $615 Million; and Free Cash...

at 06:57
The Seville multinational Persán, European leader in the production and commercialisation of detergents and fabric softeners, ended 2023 with record invoicing of 811 million euros. This figure signifies growth of 22% compared with the previous...

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, in combination with chemotherapy as adjuvant treatment, with or without radiotherapy, did...

at 06:50
Solventum today reported carve-out financial results for the first quarter ended March 31, 2024....

at 06:45
Achieves First Quarter Net Sales of $467.8 Million, Reflecting 10.2% Year-Over-Year Growth on a Reported and  Constant Currency Basis Reports Net Loss of $65.4 Million, Reflecting a 73.8% Year-Over-Year Improvement; Delivers Adjusted EBITDA of $144.9...



News published on and distributed by: